Saoirse O’Sullivan

Company: Artelo Biosciences

Job title: Vice President, Translational Sciences

Seminars:

Exploring the Clinical Development of the Fatty Acid Binding Protein 5 (FABP5) inhibitor ART26.12 11:30 am

FABP5 inhibitors as strategies for increasing endocannabinoid tone leading to analgesia Update on recent phase 1 clinical data Consideration of next stepsRead more

day: Conference Day One